Status: current, Defined. Date: 31-May 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3060191000168114 | Marcain (bupivacaine hydrochloride monohydrate 50 mg / 10 mL) injection, 10 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3060201000168112 | Marcain 0.5% (50 mg/10 mL) injection, 10 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Marcain (bupivacaine hydrochloride monohydrate 50 mg / 10 mL) injection, 10 mL vial (trade product unit of use) | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Marcain (bupivacaine hydrochloride monohydrate 50 mg / 10 mL) injection, 10 mL vial (trade product unit of use) | Is a | Marcain | true | Inferred relationship | Some | ||
| Marcain (bupivacaine hydrochloride monohydrate 50 mg / 10 mL) injection, 10 mL vial (trade product unit of use) | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Marcain (bupivacaine hydrochloride monohydrate 50 mg / 10 mL) injection, 10 mL vial (trade product unit of use) | Is a | bupivacaine hydrochloride monohydrate 0.5% (50 mg/10 mL) injection, vial | true | Inferred relationship | Some | ||
| Marcain (bupivacaine hydrochloride monohydrate 50 mg / 10 mL) injection, 10 mL vial (trade product unit of use) | has manufactured dose form | injection solution | false | Inferred relationship | Some | ||
| Marcain (bupivacaine hydrochloride monohydrate 50 mg / 10 mL) injection, 10 mL vial (trade product unit of use) | has unit of use | vial | true | Inferred relationship | Some | 1785170880 | |
| Marcain (bupivacaine hydrochloride monohydrate 50 mg / 10 mL) injection, 10 mL vial (trade product unit of use) | has intended active ingredient | bupivacaine | true | Inferred relationship | Some | 1785170879 | |
| Marcain (bupivacaine hydrochloride monohydrate 50 mg / 10 mL) injection, 10 mL vial (trade product unit of use) | has Australian BoSS | bupivacaine hydrochloride monohydrate | true | Inferred relationship | Some | 1785170879 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Marcain 0.5% (50 mg/10 mL) injection, 10 x 10 mL vials | has TPUU | True | Marcain (bupivacaine hydrochloride monohydrate 50 mg / 10 mL) injection, 10 mL vial (trade product unit of use) | Inferred relationship | Some | 1 |
| Marcain 0.5% (50 mg/10 mL) injection, 5 x 10 mL vials | has TPUU | True | Marcain (bupivacaine hydrochloride monohydrate 50 mg / 10 mL) injection, 10 mL vial (trade product unit of use) | Inferred relationship | Some | 1 |
| Marcain 0.5% (50 mg/10 mL) injection, 5 x 10 mL vials | has TPUU | True | Marcain (bupivacaine hydrochloride monohydrate 50 mg / 10 mL) injection, 10 mL vial (trade product unit of use) | Inferred relationship | Some | 1 |
| Marcain 0.5% (50 mg/10 mL) injection, 10 x 10 mL vials | has TPUU | True | Marcain (bupivacaine hydrochloride monohydrate 50 mg / 10 mL) injection, 10 mL vial (trade product unit of use) | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR